Additional Metadata
Persistent URL dx.doi.org/10.1016/S1470-2045(19)30010-5, hdl.handle.net/1765/115252
Journal The Lancet Oncology
Citation
Henricks, L.M, Lunenburg, C., Cats, A, Mathijssen, A.H.J, Guchelaar, H.J, & Schellens, J.H.M. (2019). DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply. The Lancet Oncology, 20(2), E67–E67. doi:10.1016/S1470-2045(19)30010-5